ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,147.66
0.77%
Dow Jones
43,809.81
0.92%
Gold vs US Dollar
2,669.31
0.64%
Brent Oil
73.455
0.84%
Bitcoin
97,056.88
2.86%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. E-therapeutics Plc (ETX)

  7. E-therapeutics Plc (ETX) News

E-therapeutics (ETX)

E-therapeutics Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:ETX
DateTimeSourceHeadlineSymbolCompany
31/10/202413:00UK Regulatorye-therapeutics Announces Business Updates and Interim ResultsLSE:ETXE-therapeutics Plc
09/05/202406:00RNS Regulatory NewsAIM Cancellation - e-Therapeutics PlcLSE:ETXE-therapeutics Plc
08/05/202406:00RNS Regulatory Newse-Therapeutics plc Last Day of Dealings on AIMLSE:ETXE-therapeutics Plc
03/05/202417:00RNS Regulatory NewsFTSE Russell e-therapeuticsLSE:ETXE-therapeutics Plc
29/04/202413:09RNS Regulatory Newse-Therapeutics plc Result of General MeetingLSE:ETXE-therapeutics Plc
10/04/202409:48Alliance NewsAlliance Newse-Therapeutics says company faces lack of interest as UK listingLSE:ETXE-therapeutics Plc
10/04/202406:00RNS Regulatory Newse-Therapeutics plc Proposed Fundraise of £28.9m and CancellationLSE:ETXE-therapeutics Plc
31/01/202416:30RNS Regulatory Newse-Therapeutics plc Total Voting RightsLSE:ETXE-therapeutics Plc
24/01/202410:04UK Regulatorye-Therapeutics plc Exercise of Options and Issue of EquityLSE:ETXE-therapeutics Plc
16/01/202410:34Alliance NewsAlliance NewsIN BRIEF: e-Therapeutics shares rise on strong financial yearLSE:ETXE-therapeutics Plc
16/01/202407:00UK Regulatorye-Therapeutics plc Business UpdateLSE:ETXE-therapeutics Plc
09/01/202416:04UK Regulatorye-Therapeutics plc Director Dealing and Issue of EquityLSE:ETXE-therapeutics Plc
27/12/202310:27Alliance NewsAlliance NewsIN BRIEF: e-Therapeutics shares to cease trading on OTCQXLSE:ETXE-therapeutics Plc
27/12/202307:00UK Regulatorye-Therapeutics plc Update on OTCQX Market ListingLSE:ETXE-therapeutics Plc
02/11/202314:34Alliance NewsAlliance NewsEARNINGS AND TRADING: Kanabo inks CBD deal, Taseko boosts productionLSE:ETXE-therapeutics Plc
02/11/202307:00UK Regulatorye-Therapeutics plc Strategic RWE collaboration with ArcturisLSE:ETXE-therapeutics Plc
26/10/202317:12Alliance NewsAlliance NewsEARNINGS: Riverstone Credit stays stable, Bloomsbury hails record halfLSE:ETXE-therapeutics Plc
26/10/202306:38UK Regulatorye-Therapeutics plc Interim results for the six months to 31 July 2023LSE:ETXE-therapeutics Plc
19/10/202308:54UK Regulatorye-Therapeutics plc Notice of Interim ResultsLSE:ETXE-therapeutics Plc
29/09/202315:30UK Regulatorye-Therapeutics plc Total Voting RightsLSE:ETXE-therapeutics Plc
20/09/202313:37Alliance NewsAlliance NewsTRADING UPDATES: Capital inks contract; Lansdowne becomes cash shellLSE:ETXE-therapeutics Plc
20/09/202306:00UK Regulatorye-Therapeutics plc Senior Management UpdateLSE:ETXE-therapeutics Plc
07/09/202310:47UK Regulatorye-Therapeutics plc Exercise of Options and Issue of EquityLSE:ETXE-therapeutics Plc
31/07/202315:30UK Regulatorye-Therapeutics plc Total Voting RightsLSE:ETXE-therapeutics Plc
18/07/202315:20UK Regulatorye-Therapeutics plc Result of Annual General MeetingLSE:ETXE-therapeutics Plc
06/07/202316:27UK Regulatorye-Therapeutics plc Director Dealing and Issue of EquityLSE:ETXE-therapeutics Plc
30/06/202306:00RNS Non-Regulatorye-Therapeutics plc Investor PresentationLSE:ETXE-therapeutics Plc
26/06/202306:00RNS Non-Regulatorye-Therapeutics plc Notice of Investor PresentationLSE:ETXE-therapeutics Plc
11/05/202306:00UK Regulatorye-Therapeutics plc Notice of AGM and Posting of Annual ReportLSE:ETXE-therapeutics Plc
04/05/202318:37Alliance NewsAlliance NewsTRADING UPDATES: Virgin Wines warns sales will be below City forecastsLSE:ETXE-therapeutics Plc
 Showing the most relevant articles for your search:LSE:ETX

Your Recent History

LSE
POS
Plexus
LSE
DEC
Diversified Energy
LSE
VAST
Vast Resources
LSE
SYME
Supply@me Capital
LSE
LIO
Liontrust Asset Management
LSE
MIN
Minoan
LSE
STX
Shield Therapeutics
LSE
AAZ
Anglo Asian Mining
LSE
ITM
Itm Power
LSE
GGP
Greatland Gold
LSE
TERN
Tern
LSE
BOO
Boohoo
LSE
NEXN
Nexxen
LSE
MTRO
Metro Bank
LSE
TW.
Taylor Wimpey
LSE
LLOY
Lloyds Banking
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 40%, 2 years 50% and *3 years 60%
    EU Flag

    *Across 3 years £2132.64 only £853.06